Home
Conditions
Ovarian Diseases

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,405 public trials 661 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Completed

Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery

NCT00410553

Conditions: Adnexal Diseases, Adult Solid Neoplasm, Endocrine Gland Neoplasms, +19 more
Locations: Ottawa Hospital-Civic Campus Ottawa, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

The Relationship Between Adipokines, Obesity and Insulin Resistance in Women With Polycystic Ovarian Syndrome

NCT02869750

Conditions: Adnexal Diseases, Cysts, Endocrine System Diseases, +11 more
Locations: Ahmed Kotb Cairo, Cairo Governorate, Egypt

View Trial Details

Completed

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

NCT00030706

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx, New York, United States

View Trial Details

Completed

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer

NCT01358071

Conditions: Adnexal Diseases, Disease Attributes, Disease Progression, +19 more
Locations: Ospedale San Raffaele Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

Istituto Europeo di Oncologia Milan, Italy

Istituto Nazionale Tumori IRCCS Fondazione "Giovanni Pascale" Naples, Italy

View Trial Details

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer

NCT00484432

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Fondazione San Raffaele del Monte Tabor Milan, Italy

Policlinico Universitario A. Gemelli Rome, Italy

View Trial Details

Completed

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)

NCT01863693

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Royal United Hospital; Oncology Department Bath, United Kingdom

City Hospital Birmingham, United Kingdom

Bradford Royal Infirmary; Oncology Department Bradford, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

View all 30 locations

View Trial Details

Completed

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

NCT00281632

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations: GSK Investigational Site Atlanta, Georgia, United States

GSK Investigational Site Austin, Texas, United States

GSK Investigational Site Bedford, Texas, United States

GSK Investigational Site Dallas, Texas, United States

View Trial Details

Completed

Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

NCT01544049

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Completed

Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT02046421

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +31 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

NorthShore University HealthSystem Evanston, Illinois, United States

View Trial Details

Completed

Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies

NCT00856180

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Ovarian Diseases

Ovarian Diseases trial results

Related conditions